Korea Bipolar Disorder Therapeutics Market Size By Type (Anticonvulsants, Mood Stabilizers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), And Forecast

Korea Bipolar Disorder Therapeutics Market Size And Forecast

Korea Bipolar Disorder Therapeutics Market size was valued at USD 132.80 Million in 2023 and is projected to reach USD 211.68 Million by 2030, growing at a CAGR of 6.15% from 2024 to 2030.

Growing elderly population with higher risk of bipolar disorder and expansion of mental health services are the factors driving market growth. The Korea Bipolar Disorder Therapeutics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Korea Bipolar Disorder Therapeutics Market Definition

The Korea Bipolar Disorder Therapeutics Market refers to the industry focused on the diagnosis, treatment, and management of bipolar disorder within the Korean healthcare system. It encompasses various stakeholders, including pharmaceutical companies, healthcare providers, research organizations, and patients.

The market for bipolar disorder therapeutics in Korea is driven by the increasing prevalence of bipolar disorder, a mental health condition characterized by extreme mood swings, and associated healthcare needs. The introduction of pharmacological treatments, psychotherapy approaches, and psychosocial interventions form the foundation of the market, aiming to alleviate symptoms, stabilize mood, and improve the quality of life for individuals with bipolar disorder.

The increasing prevalence of bipolar disorder in Korea drives the demand for effective therapeutics to address the needs of affected individuals. Heightened awareness of mental health disorders, including bipolar disorder, among the general population, healthcare professionals, and policymakers contributes to increased diagnosis rates and treatment-seeking behavior. Ongoing research in the field of bipolar disorder facilitates the development of innovative treatments, personalized medicine approaches, and evidence-based interventions.

The integration of personalized medicine approaches, such as pharmacogenomics and biomarker research, enables tailored treatment strategies and improved patient outcomes. The focus on patient-centered approaches, including shared decision-making, psychosocial interventions, and holistic care, provides opportunities to enhance treatment effectiveness and patient satisfaction. The adoption of digital tools, such as mobile apps and wearable devices, for self-management, remote monitoring, and telepsychiatry services, offers opportunities to improve access, engagement, and convenience of bipolar disorder therapeutics.

Korea Bipolar Disorder Therapeutics Market Overview

Formerly known as manic depression, bipolar disorder is characterized by alternate periods of depression and abnormally elevated mood. Bipolar disorder is characterized by diverse symptoms including manic, hypomanic, depressive, mixed and psychotic features, and by chronically debilitating patterns that create challenges for treatment. Bipolar disorder treatment in South Korea has seen a sharp rise in number of patients. According to the data from the National Health Insurance Service, an average annual growth rate of 4.9 percent over the five-year period before COVID situation.

In the FY 2019, According to the data based on treatments covered by the state health insurance system, the on-year increase was the highest among patients in their 70s or older at ~12 -14 percent followed by twenty-somethings with ~8-10 percent and those in their 60s with ~7-9 percent. In FY 2017, The number of female patients grew at an average annual rate of 4.6 percent, with that of male patients increasing 5.2 percent. The prevalence of bipolar disorder was estimated to be between 2 and 3 percent, or less than 0.2 percent, of the population in South Korea, despite a notable increase in the number of people receiving treatment for the mental illness.

Furthermore, advancement in the pharmaceutical industry in South Korea also benefits this industry. The pharmaceutical industry plays a crucial role in providing medications for the treatment of bipolar disorder. Companies may develop and manufacture mood stabilizers, antipsychotics, and other medications commonly prescribed to manage the symptoms of bipolar disorder. Increased investment in research and development has been a key trend. Both public and private sectors have been contributing to advancements in drug discovery, innovative therapies, and technology-driven solutions.

Furthermore, increase in number of government initiatives related to mental health issues also boost the adoption of bipolar disorder therapeutics. Recently in dec 2023, South Korea rolled out a comprehensive plan to offer mental health checkups every two years for young Koreans aged 20 to 34 and other counselling services tailored to all age groups in the first ever detailed state policy aimed at tackling the country’s consistently high suicide rates. With 25.2 suicide deaths per 100,000 people in 2022, more than twice the OECD average of 10.6 fatalities per 100,000 people, Korea has the highest suicide rate among OECD members for the first time in almost 20 years. After the assessment, the government also intends to strengthen follow-up management by collaborating with hospitals’ psychiatric departments and mental health welfare centers.

Korea Bipolar Disorder Therapeutics MarketSegmentation Analysis

The Korea Bipolar Disorder Therapeutics Market is segmented on the basis of Type and Distribution Channel.

Korea Bipolar Disorder Therapeutics Market, By Type

• Antipsychotics and Antidepressant
• Anticonvulsants
• Mood Stabilizers
• Others

To Get a Summarized Market Report By Type- 

Based on Type, The market is classified into Antipsychotics and Antidepressant, Anticonvulsants, Mood Stabilizers, and Others. Antipsychotics and Antidepressant accounted for the largest market share of 45.45% in 2022, with a market Value of USD 60.36 Million and is projected to grow at a CAGR of 6.30% during the forecast period.

Korea Bipolar Disorder Therapeutics Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

To Get a Summarized Market Report By Distribution Channel-

Based on Distribution Channel, The market is classified into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies accounted for the largest market share of 45.22% in 2022, with a market Value of USD 60.05 Million and is projected to grow at a CAGR of 6.53% during the forecast period.

Key Players

The “Korea Bipolar Disorder Therapeutics Market” study report will provide a valuable insight with an emphasis on the market. The major players in the market are Janssen Pharmaceuticals, GlaxoSmithKline, AstraZeneca, Dong-A Pharmaceutical, Novartis AG, Lotus Pharmaceuticals, Wolters Kluwer, Luye Pharma Group, H. LUNDBECK A/S, and others.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Report Scope

To Get Customized Report Scope- 

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.